Jin Han

Clinical assistant professor

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jin Han is a Clinical Assistant Professor at the University of Illinois at Chicago, USA. His research primarily focuses on sickle cell disease, examining clinical outcomes, pharmacogenomics, and health disparities among different populations. Recent works include studies on the impact of pharmacogenetics on warfarin dosing, biomarkers of disease severity, and the intersection of sickle cell disease with other health conditions such as diabetes and COVID-19.

Articles (10)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Edith Nutescu

Professor and Department Head

University of Illinois Chicago College of Pharmacy

UNITED STATES

View details

KIBUM KIM

Assistant Professor

University of Chicago

UNITED STATES

View details

James Lee

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jin Han

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing

Voxelotor and albuminuria in adults with sickle cell anaemia.

Evaluation of point-of-care International Normalized Ratio in sickle cell disease.

Genotype-Guided vs Clinically-Guided Stable Warfarin Dose Prediction and Stable Dose Establishment In A Predominantly Non-European Ancestry Population

Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.

Effects of Renin-Angiotensin Blockade and <i>APOL1</i> on Kidney Function in Sickle Cell Disease.

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease.

Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease.

Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12-year single health system-based cohort analysis.

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.

Collaborators (3)

Edith Nutescu

KIBUM KIM

James Lee

Make your next move.